Pharmafile Logo

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

- PMLiVE

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.

Download the case study here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Lupus Awareness Month

In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.

Black community representation in clinical trials

This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

Innovative Trials named Best global Patient Recruitment Company of 2021

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

Queen’s Award Highlights Video

Innovative Trials was awarded the Queen's Award for Enterprise, and this video includes highlights of the ceremony days at the HQ in Letchworth.

Innovative Trials wins the Queen’s Award

Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment